Get started
Author

Henna H.E. Hakanen

Observed names: H. Hakanen, Henna Hakanen
OpenAlex ID: A5113860696
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
2019 · Heidi M. Haikala, Johanna M. Anttila, et al. · Nature Communications · 73
PDF
Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner
2017 · Anna Kreutzman, Beatriz Colom-Fernández, et al. · Clinical Cancer Research · 47
Anti-PD1 therapy increases peripheral blood NKT cells and chemokines in metastatic melanoma patients
2018 · H. Hakanen, M. Hernberg, et al. · Annals of Oncology · 4
Abstract A130: Metastatic melanoma patients responding to PD1 therapy have higher proportion of peripheral blood NKT-cells
2019 · Henna H.E. Hakanen, Micaela Hernberg, et al. · Cancer Immunology Research · 3
Abstract LB-189: Pharmacological reactivation of MYC-dependent apoptosis cooperates with anti-PD1 immunotherapy
2019 · Heidi M. Haikala, Johanna M. Anttila, et al. · Immunology · 1
Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
2019 · Heidi M. Haikala, Johanna M. Anttila, et al. · Nature Communications · 1
PDF
Supplemental video S3 from Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner
2023 · Anna Kreutzman, Beatriz Colom-Fernández, et al.
Supplemental video S4 from Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner
2023 · Anna Kreutzman, Beatriz Colom-Fernández, et al.
Figure S5 from Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner
2023 · Anna Kreutzman, Beatriz Colom-Fernández, et al.
Supplemental video S2 from Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner
2023 · Anna Kreutzman, Beatriz Colom-Fernández, et al.
Figure S5 from Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner
2023 · Anna Kreutzman, Beatriz Colom-Fernández, et al.
Supplemental video S1 from Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner
2023 · Anna Kreutzman, Beatriz Colom-Fernández, et al.
Data from Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner
2023 · Anna Kreutzman, Beatriz Colom-Fernández, et al.
Data from Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner
2023 · Anna Kreutzman, Beatriz Colom-Fernández, et al.
Abstract LB-189: Pharmacological reactivation of MYC-dependent apoptosis cooperates with anti-PD1 immunotherapy
2019 · Heidi M. Haikala, Johanna M. Anttila, et al. · Cancer Research
Abstract A134: Single-cell roadmap of the evolution of T-cell response during anti-LAG3 and anti-PD1 combination treatment in metastatic melanoma patients
2019 · Jani Huuhtanen, Henna H.E. Hakanen, et al. · Cancer Immunology Research
Characterization of NK cells in melanoma patients treated with anti-PD1 therapy
2016 · Henna Hakanen · UEF eRepo (University of Eastern Finland)
PDF
Works count: 17
Citation count: 129
H-index: 3
I10-index: 2
Year
Topic
Type